Research graph
References from Urinary quality of life outcomes in men who were treated with image-guided intensity-modulated radiation therapy for prostate cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 2015
2015 · External reference
Prostate cancer, version 1.2014
10.6004/jnccn.2013.0174 · 2013 · External reference
Quality of life and satisfaction with outcome among prostate-cancer survivors
10.1056/nejmoa074311 · 2008 · External reference
Long-term functional outcomes after treatment for localized prostate cancer
10.1056/nejmoa1209978 · 2013 · External reference
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer
10.1002/cncr.27956 · 2013 · External reference
Toxicity analysis of dose escalation from 75.6 Gy to 81.0 Gy in prostate cancer
10.1097/coc.0b013e3181cae8c6 · 2011 · External reference
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study
10.1093/jnci/djh259 · 2004 · External reference
Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: Comparing late bowel and bladder quality of life symptoms to that of the normal population
10.1016/s0360-3016(00)01365-1 · 2001 · External reference
Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomized study
10.1016/s0360-3016(98)00406-4 · 1999 · External reference
Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes
10.1016/j.ijrobp.2013.02.010 · 2013 · External reference
Comparison of treatment volumes and techniques in prostate cancer radiation therapy
10.1097/01.coc.0000172281.32437.d4 · 2005 · External reference
A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer
10.1118/1.3013550 · 2008 · External reference
Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: Implications for defining postradiotherapy urinary toxicity
10.1016/j.eururo.2013.02.001 · 2013 · External reference
Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon
10.1186/1748-717x-7-76 · 2012 · External reference
Development of late toxicity and International Prostate Symptom Score resolution after external-beam radiotherapy combined with pulsed dose rate brachytherapy for prostate cancer
10.1016/j.ijrobp.2010.05.044 · 2011 · External reference
External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS)
10.1016/j.ijrobp.2010.03.040 · 2011 · External reference
Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients
10.1016/j.juro.2013.01.005 · 2013 · External reference
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
10.1016/j.ijrobp.2007.06.054 · 2008 · External reference
Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
10.1056/nejmoa1606221 · 2016 · External reference
